ClinicalTrials.Veeva

Menu

Evaluation of the Prevalence of Asthma in a Cohort of Children Born After IVF (Aged 11-15) Compared With a Control Group (EMCeFIV)

H

Hospital Saint Joseph

Status

Unknown

Conditions

Asthma

Treatments

Other: Comparative epidemiological survey

Study type

Observational

Funder types

Other

Identifiers

NCT02636179
RCB 2015-A00997-42

Details and patient eligibility

About

Assisted Reproduction Technologies (ART) are increasingly being used worldwide as a result of fertility decline likely caused by changes in both environment and social behaviour. Considering this large usage, it is important to evaluate the potential risk on the health of children conceived using ART.

According to the literature, children born after ART are more likely to be at higher risk of health problems than spontaneously conceived ones. Interestingly, recent studies suggested an increase of asthma prevalence in children conceived using In Vitro Fertilization (IVF).

The purpose of this study is to evaluate the prevalence of asthma in school adolescents from a cohort of children born after In Vitro Fertilization (IVF), aged 11-15 years as compared to a control group composed of the same age range spontaneously conceived individuals.

The expected outcome of this study will provide new information regarding these children to ART professionals of and to their own families, by focusing on an age range (between 11 and 15 years) for which very little information is available to date.

Full description

The methodology is a comparative epidemiological survey, between children from a historical cohort born after intraconjugal In Vitro Fertilization (singleton or twin) aged 11-15 years and a control group recruited in schools after the agreement of Academic Inspection.

Parents of the two groups will be contacted either by phone calls or through written information given in the schools. They will receive the questionnaire and an information letter, once they give their agreement to be a part of the study.

Data collection will be conducted using two anonymous questionnaires. The first questionnaire was built based on items proposed in the international Health Behaviour in School-aged Children (HBSC) survey of the World Health Organization (WHO). The second questionnaire will be sent to parents. It will focus on the pregnancy and it will be used to adjust the analysis.

This study was submitted and approved by an Institutional Review Board in France (Comité de Protection des Personnes Sud-Méditerranée II) on 11th September 2015.

Enrollment

1,792 estimated patients

Sex

All

Ages

11 to 15 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Case :
  • Children conceived by Intraconjugal In Vitro Fertilization/Intracytoplasmic Sperm Injection treatment
  • Children aged 11-15 years
  • Singleton and twins
  • School children
  • Control :
  • Children born spontaneously (without IVF)
  • Children aged 11-15 years
  • Children in the same place of schooling of the case

Exclusion criteria

  • Case :
  • Children not born by Intraconjugal In Vitro Fertilization/Intracytoplasmic Sperm Injection treatment (donor)
  • Children whose parents refuse the participation
  • Triplet and more pregnancies
  • Children who cannot attend ordinary school
  • Children from families where an infant has passed away
  • When the participation agreement was not signed
  • Control :
  • Children whose parents have benefited ART
  • When the participation agreement was not signed
  • Children whose aged and sex are unknown
  • Triplet and more pregnancies

Trial design

1,792 participants in 2 patient groups

448 children
Description:
Children aged 11-15 years from a historical cohort born after In Vitro Fertilization or Intracytoplasmic Sperm Injection at Hospital Saint Joseph of Marseille
Treatment:
Other: Comparative epidemiological survey
1344 children
Description:
Children aged 11-15 years born spontaneously schooling in the same geographic area as case
Treatment:
Other: Comparative epidemiological survey

Trial contacts and locations

1

Loading...

Central trial contact

Marie Raffray, MS

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems